SCI
PFE icon

Stableford Capital II’s Pfizer PFE Stock Holding History

Stableford Capital II’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,642
Closed -$202K – 109
2023
Q2 		$202K Sell
5,642
-1,654
-23% -$64.4K 0.09% 106
2023
Q1 		$374K Sell
7,296
-13,348
-65% -$577K 0.27% 44
2022
Q4 		$999K Sell
20,644
-1,333
-6% -$63.9K 0.54% 34
2022
Q3 		$988K Buy
21,977
+1,733
+9% +$84.2K 0.48% 42
2022
Q2 		$997K Sell
20,244
-1,309
-6% -$66.7K 0.46% 42
2022
Q1 		$1.19M Buy
21,553
+30
+0.1% +$1.56K 0.5% 48
2021
Q4 		$1.11M Sell
21,523
-624
-3% -$30.9K 0.47% 53
2021
Q3 		$923K Sell
22,147
-1,646
-7% -$72.9K 0.47% 46
2021
Q2 		$932K Buy
23,793
+388
+2% +$15.1K 0.45% 54
2021
Q1 		$848K Buy
23,405
+241
+1% +$8.56K 0.43% 54
2020
Q4 		$853K Buy
23,164
+17,217
+290% +$632K 0.5% 48
2020
Q3 		$207K Buy
+5,947
New +$209K 0.14% 62
2020
Q1 		– Sell
-15,319
Closed -$569K – 95
2019
Q4 		$569K Sell
15,319
-417
-3% -$14.9K 0.52% 47
2019
Q3 		$536K Buy
15,736
+1,609
+11% +$58.5K 0.5% 44
2019
Q2 		$581K Sell
14,127
-1,368
-9% -$54.3K 0.57% 38
2019
Q1 		$624K Sell
15,495
-581
-4% -$23.3K 0.52% 48
2018
Q4 		$666K Sell
16,076
-1,528
-9% -$63.4K 0.71% 42
2018
Q3 		$736K Sell
17,604
-1,954
-10% -$75.2K 0.49% 46
2018
Q2 		$673K Sell
19,558
-96
-0.5% -$3.28K 0.44% 43
2018
Q1 		$662K Buy
19,654
+179
+0.9% +$6.15K 0.47% 42
2017
Q4 		$669K Sell
19,475
-29,104
-60% -$992K 0.45% 50
2017
Q3 		$1.65M Buy
48,579
+2,885
+6% +$92.7K 1.19% 25
2017
Q2 		$1.46M Buy
45,694
+6,039
+15% +$190K 1.17% 26
2017
Q1 		$1.29M Buy
39,655
+27,513
+227% +$867K 1.12% 25
2016
Q4 		$374K Buy
+12,142
New +$371K 0.48% 41

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Stableford Capital II's PFE Position: Q3 2023 in Review

Stableford Capital II sold out of Pfizer (PFE) in Q3 2023, closing a stake of 5,642 shares — an estimated $202K sold.

Stableford Capital II first reported a position in PFE in Q4 2016 and held it in 25 quarters. The position peaked at $1.65M in Q3 2017. 2,928 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Stableford Capital II reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
  • Stableford Capital II sold 5,642 Pfizer shares in Q3 2023, an estimated $202K.
  • Stableford Capital II first reported a position in Pfizer in Q4 2016 and held it in 25 quarters.
  • Stableford Capital II's Pfizer position peaked at $1.65M in Q3 2017.
  • 2,928 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Stableford Capital II's 13F filing for Q3 2023, filed 30 Oct 2023.